Acute Myeloid Leukemia

Acute Myeloid Leukemia and Acute Complications Brad Clifford 10/29/08 and 10/31/08

Objectives ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Hematologic Malignancies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Acute Myeloid Leukemia ,[object Object],[object Object],[object Object],[object Object]

Myelopoiesis ,[object Object],[object Object],[object Object],[object Object]

Epidemiology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Epidemiology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Clinical symptoms ,[object Object],[object Object],[object Object],[object Object]

Clinical symptoms ,[object Object],[object Object]

Physical Findings ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Gingival Infiltration in Monocytic (AML M4 eos) Variant of AML ,[object Object]

Clinical symptoms/Physical Findings ,[object Object],[object Object]

Diagnosis ,[object Object],[object Object],[object Object],[object Object],[object Object]

FAB Classification of AML ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

WHO Classification ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

AML M3 (Promyelocytic) ,[object Object]

Case #1 ,[object Object],[object Object],[object Object],[object Object],[object Object]

Leukostasis ,[object Object],[object Object],[object Object],[object Object]

Leukostasis in AML ,[object Object]

Leukostasis ,[object Object],[object Object],[object Object],[object Object],[object Object]

Leukapheresis ,[object Object],[object Object],[object Object],[object Object]

Leukapheresis ,[object Object],[object Object],[object Object]

Tumor Lysis Syndrome ,[object Object],[object Object]

Tumor Lysis Syndrome ,[object Object],[object Object],[object Object],[object Object],[object Object]

Tumor Lysis Syndrome ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DIC (Disseminated Intravascular Coagulation) ,[object Object],[object Object],[object Object],[object Object]

Coagulation cascade ,[object Object]

DIC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DIC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Treatment of DIC ,[object Object],[object Object],[object Object],[object Object]

DIC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

CNS Involvement ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

CNS Involvement ,[object Object],[object Object],[object Object],[object Object],[object Object]

Ocular Involvement ,[object Object],[object Object],[object Object],[object Object]

Other Complications ,[object Object],[object Object],[object Object]

Treatment of AML ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Treatment ,[object Object],[object Object],[object Object]

Prognostic Factors in AML ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Disease Free Survival (EORTC/GIMEMA trial) ,[object Object]

Overall Survival (EORTC/GIMEMA trial) ,[object Object]

Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Survival in AML ,[object Object]

Treatment in Refractory or Relapsed AML ,[object Object],[object Object],[object Object],[object Object],[object Object]

Future Therapeutic Targets ,[object Object],[object Object],[object Object],[object Object]

Resources ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Acute Myeloid Leukemia

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (6)

Similar to Acute Myeloid Leukemia

Similar to Acute Myeloid Leukemia (20)

Recently uploaded

Recently uploaded (20)

Acute Myeloid Leukemia